Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Phase III,ASTX727 (Cedazuridine and Decitabine Fixed-Dose) vs IV Decitabine Subjects w/MDS and CMML

Protocol: OSU-18119

Full Title

A Phase 3, Randomized, Open-Label, Crossover Study of ASTX727 (Cedazuridine and Decitabine Fixed-Dose Combination) versus IV Decitabine in Subjects with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Chronic Myeloid Leukemia Leukemia